How to Manage Patients With Cardiac Implantable Electronic Devices Undergoing Radiation Therapy
Authors:
Open Access
- 1 September 2021
- journal article
- research article
- Published by Elsevier in JACC: Cardiooncology
- Vol. 3 (3) , 447-451
Abstract
No abstract availableKeywords
Funding Information
- Medtronic
- National Cancer Institute (P30 CA008748)
- Takeda Pharmaceuticals U.S.A.
- Abbott Laboratories
- Boston Scientific Corporation
- Biotronik
- National Institutes of Health
- Philips
This publication has 10 references indexed in Scilit:
- Cancer Statistics, 2021CA: A Cancer Journal for Clinicians, 2021
- JASTRO/JCS Guidelines for radiotherapy in patients with cardiac implantable electronic devicesJournal of Radiation Research, 2020
- Management of radiotherapy patients with implanted cardiac pacemakers and defibrillators: A Report of the AAPM TG‐203†Medical Physics, 2019
- Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart AssociationCirculation, 2019
- Management of patients with cardiac implantable electronic devices (CIED) undergoing radiotherapyInternational Journal of Cardiology, 2018
- 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devicesHeart Rhythm, 2017
- Radiotherapy-Induced Malfunction in Contemporary Cardiovascular Implantable Electronic DevicesJAMA Oncology, 2015
- Management of radiation oncology patients with a pacemaker or ICD: A new comprehensive practical guideline in The NetherlandsRadiation Oncology, 2012
- Wound healing after radiation therapy: Review of the literatureRadiation Oncology, 2012
- High incidence of implantable cardioverter defibrillator malfunctions during radiation therapy: neutrons as a probable cause of soft errorsEP Europace, 2012